[1] Bosch FX,Ribes J,Cleries R,et al. Epidemiology of hepatocellular carcinoma. Clin Liver Dis,2005,9(2):191-211.
[2] Amarapurkar D,Han KH,Chan HLY,et a1.Application of surveillance programs for hepatocellular carcinoma in the Asia-Pacific region.J Gastroenterol Hepatol,2009,2(6):955-961.
[3] Kudo M.Hepatocellular carcinoma 2009 and beyond:from the surveillance to molecular targeted therapy.Oncology,2008,75:1-12.
[4] E1-Serag HB,Rudolph KL.Hepatocellular carcinoma:epidemiology and mo-lecular carcinogenesis.Gastroenterology,2007,132(7):2557-2576.
[4] Bober J,Samek P. Surgery of the tumors of the liver. Bratial Lek Listy,2001,103:403-407.
[5] Krejci T,Skricka T,Ruzicka M,et al. Surgical liver resection in multimodal therapy of hepatic malignat affections:A 4-year study. Arch Oncol,2002,10(1): 1-5.
[6] Sumie S,Kuromatsu R,Okuda K,et al. Microvascular invasion in patients with hepatocellular carcinoma and its predictable clinicopathological factors. Ann Surg Oncol,2008,15(5):1375-1382.
[7] 田云鸿,李敬东,彭勇,等. 无肝硬化肝癌患者术后生存分析. 中华消化外科杂志,2011,10(4):305-306.
[8] Ardilcs V,Sanchez Claria R,Mazza OM,et al. Prognostic factors after resection of hepatocellular carcinoma in the non-cirrhotic liver:presentation of 51 cases. Cir Esp,2010,87(3):148-154.
[9] Roayaie S,Blume IN,Swan N,et al. A system of classifying microvascular invasion to predict outcome after resection in patients with hepatocellular carcinoma.Gastroenterology,2009,137(3):850-855.
[10] 张健,龚少娟,宋卫华,等. 肝动脉化疗栓塞治疗原发性肝癌伴门静脉癌栓的生存分析. 中华临床医师杂志(电子版),2013,7(11):4731-4733.
[11] 华永飞,陆才德,裘丰,等.术后肝动脉化疗对肝癌合并门静脉癌栓患者手术疗效的影响及预后因素分析. 中华肝胆外科杂志,2012,18(5):357-360.
[12] 江海中,邓新,钟永富. 肝癌合并门静脉癌栓的TACE治疗. 中国普通外科杂志,2015,24(1):116-120.
[13] Chung GE,Lee JH,Kim HY,et al. Transarterial chemoembolization can be safely performed in patients with hepatocellular carcinoma invading the main portal vein and may improve the overall survival. Radiology,2011,258:627-634.
[14] Luo J,Guo RP,Lai EC,et al. Transarterial chemoembolization for unresectable hepatocellular carcinoma with portal vein tumor thrombosis a prospective comparative study. Ann Surg Oncol,2011,18:413-420.
[15] Niu ZJ,Ma YL,Kang P,et al. Transarterial chemoembolization compared with conservative treatment for advanced hepatocellular carcinoma with portal vein tumor thrombus:using a new classification. Med Oncol,2012,29:2992-2997.
[16] 陈树群,吴孟超. 原发性肝癌综合治疗进展. 中华肝胆外科杂志,2009,15(4):241-243.
[17] Lai ECH,Lau WY,Lai EC,et al. The continuing challenge of hepatic cancer in Asia. Surgeon,2005, 3(3):210-215.
[18] Lee JK,Chung YH,Song BC,et al. Recurrences of hepatocellular carcinoma following initial remission by transcatheter arterial chemoembolization. Intervirology,2002,17(1):52-58.
[19] Portolani N,Coniglio A,Ghidoni S,et al. Early and late recurrence after liver resection for hepatocellular carcinoma:prognostic and therapeutic implications. Ann Surg,2006,243(2):229-235. |